These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31299528)

  • 1. Screening for depression in youth with epilepsy: Psychometric analysis of NDDI-E-Y and NDDI-E in a French population.
    Viellard M; Villeneuve N; Milh M; Lépine A; Micoulaud-Franchi JA; McGonigal A
    Epilepsy Behav; 2019 Sep; 98(Pt A):19-26. PubMed ID: 31299528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of specific depressive symptom clusters in youth with epilepsy: The NDDI-E-Y versus Neuro-QOL SF.
    Kellermann TS; Mueller M; Carter EG; Brooks B; Smith G; Kopp OJ; Wagner JL
    Epilepsia; 2017 Aug; 58(8):1370-1379. PubMed ID: 28597917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy.
    Wagner JL; Kellermann T; Mueller M; Smith G; Brooks B; Arnett A; Modi AC
    Epilepsia; 2016 Aug; 57(8):1265-70. PubMed ID: 27354177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.
    Micoulaud-Franchi JA; Lagarde S; Barkate G; Dufournet B; Besancon C; Trébuchon-Da Fonseca A; Gavaret M; Bartolomei F; Bonini F; McGonigal A
    Epilepsy Behav; 2016 Apr; 57(Pt A):211-216. PubMed ID: 26994447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Georgian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).
    Silagadze K; Kasradze S; Silagadze T; Lomidze G
    Epilepsy Behav; 2019 Dec; 101(Pt A):106587. PubMed ID: 31698261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Indian version of Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).
    Rashid H; Katyal J; Tripathi M; Sood M; Gupta YK
    Epilepsy Behav; 2019 Jun; 95():75-78. PubMed ID: 31026787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One step closer to a global tool for rapid screening of major depression in epilepsy: validation of the French NDDI-E.
    Micoulaud-Franchi JA; Barkate G; Trébuchon-Da Fonseca A; Vaugier L; Gavaret M; Bartolomei F; McGonigal A
    Epilepsy Behav; 2015 Mar; 44():11-6. PubMed ID: 25597527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) Serbian version.
    Ristić AJ; Pjevalica J; Trajković G; Parojčić A; Mihajlović A; Vojvodić N; Baščarević V; Popović T; Janković S; Sokić D
    Epilepsy Behav; 2016 Apr; 57(Pt A):1-4. PubMed ID: 26900772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the efficacy of 2 screening measures for depression in people with epilepsy.
    Gandy M; Sharpe L; Perry KN; Miller L; Thayer Z; Boserio J; Mohamed A
    Neurology; 2012 Jul; 79(4):371-5. PubMed ID: 22786594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Chinese version of the Hamilton Rating Scale for Depression in adults with epilepsy.
    Lin J; Wang X; Dong F; Du Y; Shen J; Ding S; Wang L; Ye M; Wang Y; Xia N; Zheng R; Chen H; Xu H
    Epilepsy Behav; 2018 Dec; 89():148-152. PubMed ID: 30415137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-short screening instruments for major depressive episode and generalized anxiety disorder in epilepsy: The NDDIE-2 and the GAD-SI.
    Micoulaud-Franchi JA; Bartolomei F; McGonigal A
    J Affect Disord; 2017 Mar; 210():237-240. PubMed ID: 28064112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI).
    de Oliveira GN; Lessa JM; Gonçalves AP; Portela EJ; Sander JW; Teixeira AL
    Epilepsy Behav; 2014 May; 34():50-4. PubMed ID: 24681386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Russian version of neurological disorders depression inventory for epilepsy (NDDI-E).
    Zinchuk M; Kustov G; Pashnin E; Gersamia A; Rider F; Yakovlev A; Guekht A
    Epilepsy Behav; 2020 Dec; 113():107549. PubMed ID: 33246233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a German version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E).
    Metternich B; Wagner K; Buschmann F; Anger R; Schulze-Bonhage A
    Epilepsy Behav; 2012 Dec; 25(4):485-8. PubMed ID: 23153711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the Taiwanese version of the Neurological Disorders Depression Inventory for Epilepsy (Tw-NDDI-E).
    Shih YC; Chou CC; Lu YJ; Chou YH; Yu HY
    Seizure; 2020 Oct; 81():53-57. PubMed ID: 32745948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the Lithuanian version of the NDDI-E in persons with epilepsy and suicidal ideation.
    Puteikis K; Mameniškienė R
    Epilepsy Behav; 2022 Nov; 136():108913. PubMed ID: 36155364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the performance of two depression rating scales in patients with epilepsy in southern China.
    Xia NG; Ding SQ; Lin JH; Dong FR; Du YR; Wang XS; Chen YY; Zhu ZG; Zheng RY; Xu HQ
    Epilepsy Behav; 2020 May; 106():107025. PubMed ID: 32199345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cutoff score of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) for detecting major depressive disorder: A meta-analysis.
    Kim DH; Kim YS; Yang TW; Kwon OY
    Epilepsy Behav; 2019 Mar; 92():61-70. PubMed ID: 30616067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Chinese version of the Neurological Disorders Depression Inventory for Epilepsy (C-NDDI-E) in West China.
    Tong X; An D; Lan L; Zhou X; Zhang Q; Xiao F; Park SP; Kanemoto K; Kanner AM; Zhou D
    Epilepsy Behav; 2015 Jun; 47():6-10. PubMed ID: 26004785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating quality of life in epilepsy: The role of screening for adverse drug effects, depression, and anxiety.
    Micoulaud-Franchi JA; Bartolomei F; Duncan R; McGonigal A
    Epilepsy Behav; 2017 Oct; 75():18-24. PubMed ID: 28818810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.